Bitcoin Can’t Hold $85,000. ETF Outflows Explain Why.
BTC is about 34% below its October 2025 peak, and spot ETFs keep bleeding cash.
Nestlé’s Volume Growth Changes the Bond-vs-Staples Debate
The question every income-oriented investor has been avoiding is this: if bonds pay 5%, why bother with consumer staples at…
Amazon built a robot that can “feel”
October 22, 2026 Bonus Content: GE Aerospace’s Orders Surged 49%. The Stock Fell Anyway. A note from our friends at…
Hermès Missed. Now Investors Must Ask What They Were Paying For.
China hit accessories, and the luxury stock that held a premium suddenly looks more cyclical.
D.C. Wants Experienced Drone Makers. This One Has 25 Years Behind It.
October 22, 2026 Bonus Content: Sutures Are Losing Ground. Medtronic Is Positioned to Profit. A note from our friends at…
Linde’s Hydrogen Steel Play Has CBAM Behind It
EU CBAM entered its definitive phase January 1, 2026. Q3 earnings arrive October 29.
Intuitive Surgical Is Down 29% From Its High. The Decade-Long Case Is Not.
Intuitive Surgical does not give investors many easy entry points. Tuesday’s after-hours selloff may be one of the rare exceptions…
Trump’s dollar plan, explained
October 21, 2026 Bonus Content: Jio Platforms Is Subscribed 2.36x. What That Tells Long-Term Investors. A note from our friends…
Ionis Gets Paid Every Time GSK Sells Its New Hepatitis B Drug
With Hibsago now FDA-approved and Ionis collecting 10 to 12% royalties, the smaller company may be the cleaner bet on this breakthrough.
Market icon: “This market has me extremely worried…”
October 20, 2026 Bonus Content: VZ Is Cashing In as Big Tech Seizes the Ocean Floor A note from our…